Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experiment

• Ngā kaituhi matua: Steven R. Feldman (Author), Jacob P. Thyssen (Author), Marco Boeri (Author), Robert Gerber (Author), Maureen P. Neary (Author), Amy Cha (Author), Brett Hauber (Author), Joseph C. Cappelleri (Author), Jason Xenakis (Author), Colton Leach (Author), Joshua Zeichner (Author)
• Hōputu: Pukapuka
• I whakaputaina: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

AbstractPurpose: Topical treatments for mild-to-moderate (MM) atopic dermatitis (AD) include emollients, corticosteroids, calcineurin inhibitors, a Janus kinase inhibitor, and a phosphodiesterase 4 inhibitor, which differ in multiple ways. This study aimed to quantify the conditional relative import...